Concepedia

Author

Sonia Poli

Addex Therapeutics (Switzerland)ORCID

Also Known As

Poli, S.M., Poli, Sonia M., S Poli, S. POLI, S. Poli, S.M. Poli, Sonia M. Poli, Sonia Maria Poli, Sonia Poli

63

Publications

2.6K

Citations

28

H-Index

68

Concepts

All Affiliations

Addex Therapeutics (Switzerland)Roche (Switzerland)University of PaviaCentre National de la Recherche ScientifiqueJanssen (Belgium)
SP

About

Sonia Poli is an author at Addex Therapeutics (Switzerland) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

16

670

2

Natural Sciences

6

6

220

3

Engineering

4

4

185

4

Health Sciences

1

1

17

5

Public Health

1

1

41

Sonia Poli

×

39

Publications

2.3K

Citations

27

H-Index

YearCitations

A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat

François Jenck, Juergen Wichmann, Frank M. Dautzenberg,

Proceedings of the National Academy of Sciences

2000

274

Comparison of in Vitro P-Glycoprotein Screening Assays:  Recommendations for Their Use in Drug Discovery

Dietmar Schwab, Holger Fischer, Ali Tabatabaei,

Journal of Medicinal Chemistry

2003

200

Influence of the 5-HT<sub>6</sub>Receptor on Acetylcholine Release in the Cortex:  Pharmacological Characterization of 4-(2-Bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a Potent and Selective 5-HT<sub>6</sub>Receptor Antagonist

Claus Riemer, Edilio Borroni, Bernard Levet‐Trafit,

Journal of Medicinal Chemistry

2003

191

Endogenous Proteins Controlling Amyloid β-Peptide Polymerization

Bernd Bohrmann, Lars O. Tjernberg, Pascal Kuner,

Journal of Biological Chemistry

1999

154

Interaction of Sulfaphenazole Derivatives with Human Liver Cytochromes P450 2C:  Molecular Origin of the Specific Inhibitory Effects of Sulfaphenazole on CYP 2C9 and Consequences for the Substrate Binding Site Topology of CYP 2C9

Annah Mancy, Sylvie Dijols, Sonia Poli,

Biochemistry

1996

122

A Potent and Selective Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator Improves Movement in Rodent Models of Parkinson's Disease

Emmanuel Le Poul, Christelle Boléa, Françoise Girard,

Journal of Pharmacology and Experimental Therapeutics

2012

99

ADX71743, a Potent and Selective Negative Allosteric Modulator of Metabotropic Glutamate Receptor 7: In Vitro and In Vivo Characterization

Mikhail Kalinichev, Mélanie Rouillier, Françoise Girard,

Journal of Pharmacology and Experimental Therapeutics

2012

97

Mechanism based neurotoxicity of mGlu5 positive allosteric modulators – Development challenges for a promising novel antipsychotic target

Sophie Parmentier‐Batteur, Peter H. Hutson, Karsten Menzel,

Neuropharmacology

2013

93

The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model

Erwan Bézard, Elsa Y. Pioli, Qin Li,

Movement Disorders

2014

76

Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of Depression

Brice Campo, Mikhail Kalinichev, Nathalie Lambeng,

Journal of Neurogenetics

2011

75

Page 1